Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 42 results.
User Information
Export Records
  1. 1.   Transforming Growth Factor-ß (TGF-ß) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.
  2. Tang, Liu-Ya; Heller, Mary; Meng, Zhaojing; Yu, Li-Rong; Tang, Yi; Zhou, Ming; Zhang, Ying E
  3. The Journal of biological chemistry. 2017, Mar 10; 292(10): 4302-4312.
  1. 2.   Transforming growth factor beta in cancer: Janus, the two-faced god
  2. Salomon, D.
  3. Journal of the National Cancer Institute. 2014, Feb; 106(2): djt441.
  1. 3.   Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage
  2. Kim, W. K.; Sun, Y.; Do, H.; Autissier, P.; Halpern, E. F.; Piatak, M.; Lifson, J. D.; Burdo, T. H.; McGrath, M. S.; Williams, K.
  3. Journal of Leukocyte Biology. 2010, Apr; 87(4): 557-567.
  1. 4.   Properties of non-coding DNA and identification of putative cis-regulatory elements in Theileria parva
  2. Guo, X. A.; Silva, J. C.
  3. Bmc Genomics. 2008 9
  1. 5.   The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20
  2. Shembade, N.; Harhaj, N. S.; Parvatiyar, K.; Copeland, N. G.; Jenkins, N. A.; Matesic, L. E.; Harhaj, E. W.
  3. Nature Immunology. 2008 9(3): 254-262.
  1. 6.   Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Chatterjee, N.; Yeager, M.; Welch, R.; Chanock, S. J.; Weissfeld, J. L.; Schoen, R. E.; Hayes, R. B.
  3. Carcinogenesis. 2007, Sep; 28(9): 1965-1970.
  1. 7.   Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells
  2. Huang, J.; Hu, J. Y.; Bian, X. W.; Chen, K. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O. M. Z.; Wang, J. M.
  3. Cancer Research. 2007, Jun; 67(12): 5906-5913.
  1. 8.   Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus(mac251)-infected macaques
  2. Hryniewicz, A.; Price, D. A.; Moniuszko, M.; Boasso, A.; Edghill-Spano, Y.; West, S. M.; Venzon, D.; Vaccari, M.; Tsai, W. P.; Tryniszewska, E.; Nacsa, J.; Villinger, F.; Ansari, A. A.; Trindade, C. J.; Morre, M.; Brooks, D.; Arlen, P.; Brown, H. J.; Kitchen, C. M. R.; Zack, J. A.; Douek, D. C.; Shearer, G. M.; Lewis, M. G.; Koup, R. A.; Franchini, G.
  3. Journal of Immunology. 2007, Mar; 178(6): 3492-3504.
  1. 9.   Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells
  2. Akel, S.; Bertolette, D.; Petrow-Sadowski, C.; Ruscetti, F. W.
  3. Platelets. 2007 18(8): 566-578.
  1. 10.   Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
  2. Yang, Y. A.; Zhang, G. M.; Feigenbaum, L.; Zhang, Y. E.
  3. Cancer Cell. 2006, Jun; 9(6): 445-457.
  1. 11.   Unraveling the pros and cons of interferon-gamma gene regulation
  2. Young, H. A.
  3. Immunity. 2006, MAY; 24(5): 506-507.
  1. 12.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 13.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 14.   Transforming growth factor beta 1 (TGF beta 1) polymorphisms and advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Welch, R.; Chanock, S. J.; Pinsky, P.; Weissfeld, J. L.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2756S-2756S.
  1. 15.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 16.   MRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers
  2. Hibbert, C. S.; Mirro, J.; Rein, A.
  3. Journal of Virology. 2004, OCT; 78(20): 10927-10938.
  1. 17.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 18.   A potential role for imaging technology in anticancer efficacy evaluations
  2. Hollingshead, M. G.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Shoemaker, R.; Melillo, G.; Sausville, E. A.
  3. European Journal of Cancer. 2004 40(6): 890-898.
  1. 19.   FlexProt: Alignment of flexible protein structures without a predefinition of hinge regions
  2. Shatsky, M.; Nussinov, R.; Wolfson, H. J.
  3. Journal of Computational Biology. 2004 11(1): 83-106.
  1. 20.   Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins - A molecular link of two tumor suppressor pathways
  2. Birchenall-Roberts, M. C.; Fu, T.; Bang, O. S.; Dambach, M.; Resau, J. H.; Sadowski, C. L.; Bertolette, D. C.; Lee, H. J.; Kim, S. J.; Ruscetti, F. W.
  3. Journal of Biological Chemistry. 2004 279(24): 25605-25613.
  1. 21.   Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell- factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation
  2. Akel, S.; Petrow-Sadowski, C.; Laughlin, M. J.; Ruscetti, F. W.
  3. Stem Cells. 2003 21(5): 557-567.
  1. 22.   Endocrine expression of the active form of TGF-beta 1 in the TGF-beta 1 null mice fails to ameliorate lethal phenotype
  2. Longenecker, G.; Thyagarajan, T.; Nagineni, C. N.; Flanders, K. C.; Factor, V.; Miller, G.; Ward, J. M.; Nalca, A.; Rangnekar, V. M.; Thorgeirsson, S.; Kulkarni, A. B.
  3. Cytokine. 2002 18(1): 43-50.
  1. 23.   Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects
  2. Yang, Y. A.; Dukhanina, O.; Tang, B. W.; Mamura, M.; Letterio, J. J.; MacGregor, J.; Patel, S. C.; Khozin, S.; Liu, Z. Y.; Green, J.; Anver, M. R.; Merlino, G.; Wakefield, L. M.
  3. Journal of Clinical Investigation. 2002 109(12): 1607-1615.
  1. 24.   Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. Ramakrishna, G.; Perella, C.; Birely, L.; Diwan, B. A.; Fornwald, L. W.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2002 179(1): 21-34.
  1. 25.   TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis
  2. Plisov, S. Y.; Yoshino, K.; Dove, L. F.; Higinbotham, K. G.; Rubin, J. S.; Perantoni, A. O.
  3. Development. 2001 128(7): 1045-1057.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel